Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriyuki Sakakibara is active.

Publication


Featured researches published by Noriyuki Sakakibara.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2003

Management of mandibular osteoradionecrosis corresponding to the severity of osteoradionecrosis and the method of radiotherapy.

Ken-ichi Notani; Yutaka Yamazaki; Hideyuki Kitada; Noriyuki Sakakibara; Hiroshi Fukuda; Keiiti Omori; Motoyasu Nakamura

To demonstrate appropriate treatment methods for mandibular osteoradionecrosis (ORN) by evaluating previous results.


Head and Neck-journal for The Sciences and Specialties of The Head and Neck | 2005

Clinical value of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma.

Yutaka Yamazaki; Itsuo Chiba; Atsuko Hirai; Chiharu Satoh; Noriyuki Sakakibara; Ken-ichi Notani; Tadashi Iizuka; Yasunori Totsuka

The purpose of this study was to investigate the incidence and clinical significance of genetically diagnosed lymph node micrometastasis for patients with oral squamous cell carcinoma (SCC).


Anti-Cancer Drugs | 1999

Inhibition of Na+,K+-ATPase by cisplatin and its recovery by 2-mercaptoethanol in human squamous cell carcinoma cells.

Noriyuki Sakakibara; Kuniaki Suzuki; Hiroyuki Kaneta; Yoshitaka Yoshimura; Yoshiaki Deyama; Akira Matsumoto; Hiroshi Fukuda

Na+,K+-ATPase (EC 3.6.1.37) is assumed to be involved in the transport of cisplatin [cis-diamminedichloroplatinum(II)] into cells and to act as a modulator of 5-fluorouracil (5-FU) in combination therapy of cisplatin and 5-FU. Whereas inhibition of Na+,K+-ATPase activity by cisplatin is expected to have effects on both anti-cancer therapy and nephrotoxicity, the inhibition mechanism remains to be elucidated. We studied the inhibition of Na+,K+-ATPase activity by cisplatin using an enzyme partially purified from Ca9-22 cells derived from a human squamous cell carcinoma of the gingiva. Cisplatin inhibited the Na+,K+-dependent ATP hydrolysis activity, and this inhibition depended on both the concentration of cisplatin and the preincubation time with cisplatin. The time-dependent inhibition was thought to be caused by a slow change of cisplatin from the inactive to the active form. We further tested the effect of cisplatin on the partial reactions of the enzyme, Na+-dependent ATP hydrolysis and K+-dependent pnitrophenylphosphate hydrolysis activities to determine which step in the reaction sequence of Na+,K+-ATPase was inhibited. Cisplatin inhibited both activities depending on its concentration and the preincubation time, whereas the Na+-dependent ATP hydrolysis activity was inhibited even at lower concentrations. Formation of a phosphointermediate of Na+,K+-ATPase was also inhibited by cisplatin depending on the concentration and preincubation time. Cisplatin (500 microM) and 8-fold higher concentration of 2-mercaptoethanol (2-ME; 4 mM) prevented inactivation of the enzyme by cisplatin, and the Na+,K+-ATPase activity inhibited by pretreatment with cisplatin was also recovered almost completely by 2-ME. These results suggest that the active form of cisplatin inhibits the Na+,K+-ATPase activity by inhibiting the formation of a phosphointermediate of the enzyme and that the inhibition by cisplatin is arrested by an addition of thiol group.


Clinical Nuclear Medicine | 2008

Cervical toxoplasmic lymphadenitis can mimic malignant lymphoma on FDG PET.

Yutaka Yamazaki; Yoshimasa Kitagawa; Hironobu Hata; Noriyuki Sakakibara; Masanobu Shindoh; Nagara Tmamaki

A 63-year-old woman presented with indolent swelling in her right submandibular region. CT and MRI demonstrated enlarge- ment of multiple right neck lymph nodes with homogeneous en- hancement. Because malignant lymphoma was suspected, whole body FDG PET was performed, which revealed accumulation of FDG in the submandibular region and additional increased accumu- lation with delayed imaging. After excisional biopsy of the enlarged right submandibular lymph node, histopathology showed evidence of probable toxoplasmic lymphadenitis. The patient had a history of exposure to cats and her serum toxoplasmic antibody titer was high. These findings led to a final diagnosis of toxoplasmosis. Increased uptake on FDG PET may occur in patients with cervical toxoplasmic lymphadenitis.


Asian Journal of Oral and Maxillofacial Surgery | 2002

Osteoradionecrosis of the Mandible — Factors Influencing Severity

Ken-ichi Notani; Yutaka Yamazaki; Shingo Moriya; Noriyuki Sakakibara; Hiroyuki Nakamura; Masaaki Watanabe; Hiroshi Fukuda

Abstract Objectives: To examine the factors influencing the severity of mandibular osteoradionecrosis to provide helpful data for the management of this condition. Patients and Methods: From 1963 to 1997, eighty seven patients with mandibular osteoradionecrosis who had received brachytherapy alone, combined radiotherapy and brachytherapy, or external radiotherapy alone were managed by conservative and/or surgical treatment. The time interval from completion of radiotherapy to the onset of osteoradionecrosis, the incidence of osteoradionecrosis with regard to the radiotherapy modality and the dose of external radiotherapy and brachytherapy used, and the factors involved in initiating osteoradionecrosis were examined. Results: There was a long term irreversible detrimental effect of irradiation. Most cases of osteoradionecrosis developed spontaneously within 36 months. External radiotherapy had greater detrimental effects on the development of osteoradionecrosis than did brachytherapy. When the onset of osteoradionecrosis was delayed and patients received a high dose of external irradiation, severe osteoradionecrosis developed. Conclusion: Conservative treatment or radical surgery should be selected for patients with osteoradionecrosis of the mandible by considering the previous radiotherapy modality and the time interval before the onset of osteoradionecrosis, as well as the dose of irradiation.


Journal of Japan Society for Oral Tumors | 1999

Distant metastases in patients with squamous cell carcinoma of oral cavity. Analysis of critical factors that influence development of distant metastasis with locoregional control.

Hiroyuki Harada; Kanchu Tei; Shujiroh Makino; Hideaki Kitada; Noriyuki Sakakibara; Ken-ichi Notani; Hiroshi Fukuda; Mitsunobu Ono; Yasunori Totsuka; Tsukasa Muramatsu

口腔癌の遠隔転移発現に関与する因子を明らかにする目的で, 頸部転移様相をはじめとする臨床的・病理組織学的所見を検討した。1974年から1995年までに根治的治療を行った口腔扁平上皮癌535例中, 原発・頸部制御例は427例であった。頸部転移の有無で遠隔転移の発現率をみると頸部転移群では25/112 (22.3%) , 非転移群では5/315 (1.6%) で両群間に有意差がみられた (p<.001) 。このことより頸部転移群は遠隔転移のハイリスクグループであることが明らかとなった。今回ハイリスクグループである頸部転移群112例を対象に, さらに関連性の高い因子を検討すべく多重ロジスティック解析を行った。その結果, 転移リンパ節レベルのオッズ比が3.960と最も高く, レベルの進展した症例に対する遠隔転移の対策が必要と考えられた。


Journal of Japan Society for Oral Tumors | 1996

Therapeutic results for squamous cell carcinoma of upper gingiva and alveolus.

Kanchu Tei; Hideaki Kitada; Noriyuki Sakakibara; Tomomi Yamasita; Shujirou Makino; Akira Satou; Ken-ichi Notani; Hiroshi Fukuda; Hiroyuki Nakamura; Masataka Kida


Toukeibu Gan | 2005

COMPLICATIONS OF MANDIBULAR SEGMENTAL OSTEOTOMY FOLLOWING CARCINOMA OF THE LOWER ALVEOLUS

Mitsunobu Ono; Hideaki Kitada; Masashi Takano; Noriyuki Sakakibara; Kanchu Tei; Ken-ichi Notani; Yoshimasa Kitagawa; Yasunori Totsuka


Journal of Japan Society for Oral Tumors | 2013

Oral and maxillofacial reconstruction using rectus abdominis myocutaneous flap (Original Article)

Shujiroh Makino; Masashi Takano; Hideaki Kitada; Tomomi Yamashita; Noriyuki Sakakibara; Ken-ichi Notani; Yoshimasa Kitagawa; Kanchu Tei


Journal of Japanese Society of Oral Oncology | 2010

Mandibular reconstruction using vascularized bone graft: indications of fibular flap, scapular flap and iliac crest flap: ―腓骨皮弁,肩甲骨皮弁,腸骨皮弁の使い分けについて―

Shujiroh Makino; Hideaki Kitada; Masashi Takano; Noriyuki Sakakibara; Ken-ichi Notani; Yoshimasa Kitagawa; Yasunori Totsuka

Collaboration


Dive into the Noriyuki Sakakibara's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge